1. Educational weight loss interventions in obese and overweight adults with type 2 diabetes: a systematic review and meta‐analysis of randomized controlled trials. Issue 4 (22nd December 2019) Authors: Maula, A.; Kai, J.; Woolley, A. K.; Weng, S.; Dhalwani, N.; Griffiths, F. E.; Khunti, K.; Kendrick, D. Journal: Diabetic medicine Issue: Volume 37:Issue 4(2020) Page Start: 623 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evolocumab use and LDL-C lowering in a cohort of european patients with familial hypercholesterolemia (FH) - Results from the Heymans study. (August 2021) Authors: Sibartie, M.; Dhalwani, N.; Bridges, I.; Ebenbichler, C.; Filardi, P. Peronne; Vogt, A.; Bruckert, E. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e253 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evolocumab use and LDL-C lowering in a cohort of European patients with familial hypercholesterolemia (FH) - results from the Heymans study. (August 2021) Authors: Sibartie, M.; Dhalwani, N.; Ebenbichler, C.; Filardi, P. Perrone; Bruckert, E. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Final results from the pan-European observational heymans study suggest a mismatch between guidelines and PCSK9i reimbursement criteria. (August 2022) Authors: Ray, K.K.; Bruckert, E.; Perrone-Filardi, P.; Ebenbichler, C.; Vogt, A.; Bridges, I.; Sibartie, M.; Dhalwani, N. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗